MaxCyte, which provides cell engineering devices and services, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company is currently listed on London's AIM (MXCT).
MaxCyte's Flow Electroporation technology facilitates the complex engine
Immuneering, a preclinical biotech targeting signaling pathways to treat cancer and neurological diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Immuneering's oncology programs target mutations of the MAPK and mTOR pathways, whic
Omega Therapeutics, a preclinical biotech developing gene therapies for cancer and other diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Omega Therapeutics aims to use its proprietary OMEGA Epigenomic Programming platform to pion
RxSight, a commercial-stage provider of an intraocular lens that can be adjusted after cataract surgery, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
RxSight markets its RxSight Light Adjustable Lens system, comprised of the RxSigh
Generation Income Properties, an internally managed net lease REIT focused on single-tenant commercial properties, raised the proposed price range for its upcoming IPO on Friday.
The Tampa, FL-based company now plans to raise $16 million by offering 1.3 million units at a price
Galata Acquisition, a blank check company formed by Callaway Capital and Weiss targeting financials and fintech in emerging markets, raised $125 million by offering 12.5 million units at $10. Units consist of one share of common stock and one-half of a warrant exercisable at
Sentage Holdings, which provides consumer loan collection, recommendation, and payment services in China, raised $20 million by offering 4.0 million shares at $5, the low end of the range of $5 to $6. At the $5 offer price, Sentage commands a market value of $70 million.The Shang
Building upon the record number of listings in the first quarter, Nasdaq has extended its listings leadership to 30 consecutive quarters, welcoming 410 initial public offerings in the first half of this year and raising a total of $106 billion.
Building upon the record number of listings in the first quarter, Nasdaq has extended its listings leadership to 30 consecutive quarters, welcoming 410 initial public offerings in the first half of this year and raising a total of $106 billion.
Building upon the record number of listings in the first quarter, Nasdaq has extended its listings leadership to 30 consecutive quarters, welcoming 395 initial public offerings in the first half of this year and raising a total of $103 billion.
Building upon the record number of listings in the first quarter, Nasdaq has extended its listings leadership to 30 consecutive quarters, welcoming 395 initial public offerings in the first half of this year and raising a total of $103 billion.
Nasdaq President and Chief Executive Officer Adena Friedman’s efforts to further strengthen the company’s listings leadership and enhance market integrity have landed her in Barron’s Top 30 CEOs of 2021.
Nasdaq President and Chief Executive Officer Adena Friedman’s efforts to further strengthen the company’s listings leadership and enhance market integrity have landed her in Barron’s Top 30 CEOs of 2021.
To understand why I got excited about this particular company, first we need to understand the common problems with pharma and biotech investing, so let’s start there.
Krispy Kreme reported a jump in revenue for the first quarter of 2021 as the doughnut chain readies its return to the stock market after five years, according to a filing for an initial public offering (IPO) that was made public on Tuesday.
Since the launch of Nasdaq First North Growth Market, there have been 100 companies with an accumulated market cap of over 76.3 billion euros that have matured and transferred over to our Nasdaq Nordic Main Market.
Since the launch of Nasdaq First North Growth Market, there have been 100 companies with an accumulated market cap of over 76.3 billion euros that have matured and transferred over to our Nasdaq Nordic Main Market.
Since the launch of Nasdaq First North Growth Market, there have been 100 companies with an accumulated market cap of over 70.1 billion euros that have matured and transferred over to our Nasdaq Nordic Main Market.
Special purpose acquisition companies (SPACS) have raked in a record $100 billion through initial public offerings so far in 2021, data from Refinitiv showed, in what has been Wall Street's biggest gold rush in recent years.